Key result
Post-COVID-19 condition linked to ~338% higher odds of post-exertional malaise versus SARS-CoV-2 negatives.
Why the study?
Exercise-based treatments can be harmful in post-COVID-19 condition patients with post-exertional malaise or orthostatic intolerance, but these symptoms are not routinely assessed.
Cohort (n=3,783)
Odds Ratio: 4.38 (95% CI 3.01–6.38)
Absolute Event Rate: 48.1% vs 20.4%
High proportions of post-exertional malaise and orthostatic intolerance are observed in people living with post-COVID-19 condition, highlighting the need for standard screening to prevent harm from exercise-based treatments.
May warrant routine assessment of post-exertional malaise in post-COVID care; leaves open causal pathways and management strategies.
Background Exercise-based treatments can be harmful in people who were SARS-CoV-2 positive and living with post-COVID-19 condition (PL-PCC) and who have post-exertional malaise (PEM) or orthostatic intolerance (OI). Nevertheless, PEM and OI are not routinely assessed by clinicians. We estimated PEM and OI proportions in PL-PCC, as well in people not living with PCC (PnL-PCC) and negatives (i.e., never reported a SARS-CoV-2 positive test), and identified associated factors. Methods Participants from the PRIME post-COVID study were included. PEM and OI were assessed using validated questionnaires. PCC was defined as feeling unrecovered after SARS-CoV-2 infection. Multivariable regression analyses to study PEM and OI were stratified for sex. Results Data from 3,783 participants was analyzed. In PL-PCC, proportion of PEM was 48.1% and 41.2%, and proportion of OI was 29.3% and 27.9% in women and in men, respectively. Proportions were higher in PL-PCC compared to negatives, for PEM in women OR=4.38 [95%CI:3.01-6.38]; in men OR=4.78 [95%CI:3.13-7.29]; for OI in women 3.06 [95%CI:1.97-4.76]; in men 2.71 [95%CI:1.75-4.21]. Associated factors were age ≤60 years, ≥1 comorbidities and living alone. Conclusions High proportions of PEM and OI are observed in PL-PCC. Standard screening for PEM and OI is recommended in PL-PCC, to promote appropriate therapies. Trial registration ClinicalTrials.gov identifier: NCT05128695
No takes yet. Share an insight, caveat, or question.
Pagen et al. (2023) conducted a cohort in Post-COVID-19 condition (n=3,783). Post-COVID-19 condition vs. SARS-CoV-2 negatives was evaluated on Post-exertional malaise (PEM) in women (OR 4.38, 95% CI 3.01-6.38). People living with post-COVID-19 condition had significantly higher odds of experiencing post-exertional malaise compared to SARS-CoV-2 negatives, with an odds ratio of 4.38 in women and 4.78 in men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: